Tulopafant is a platelet activating factor (PAF) receptor antagonist. References: O'Hair DP, Roza AM, Komorowski R, Moore G, McManus RP, Johnson CP, Adams MB, Pieper GM. Tulopafant, a PAF receptor antagonist, increases capillary patency and prolongs survival in discordant cardiac xenotransplants. J Lipid Mediat. 1993 May;7(1):79-84. PubMed PMID: 8395256.

纯度：≥98%

CAS：116289-53-3